ABSTRACT
Although personal melanoma risk factors are well established, the contribution of socioeconomic factors, including clothing styles, social norms, medical paradigms, perceptions of tanned skin, economic trends, and travel patterns, to melanoma incidence has not been fully explored. We analyzed artwork, advertisements, fashion trends, and data regarding leisure-time activities to estimate historical changes in UV skin exposure. We used data from national cancer registries to compare melanoma incidence rates with estimated skin exposure and found that they rose in parallel. Although firm conclusions about melanoma causation cannot be made in an analysis such as this, we provide a cross-disciplinary, historical framework in which to consider public health and educational measures that may ultimately help reverse melanoma incidence trends.
Subject(s)
Melanoma/epidemiology , Sunbathing/statistics & numerical data , Adolescent , Adult , Clothing/history , Culture , Female , Health Knowledge, Attitudes, Practice , History, 20th Century , Humans , Incidence , Male , Melanoma/etiology , Skin/radiation effects , Sunbathing/history , Suntan , United States , Young AdultABSTRACT
Letters to the Editor are welcomed for publication (subject to editing). Letters must be signed by all authors, and must not exceed two pages of text including references. Letters should not duplicate material submitted or published in other journals. Prepublication proofs will not be provided.
Subject(s)
Immunoglobulin G/adverse effects , Immunosuppressive Agents/adverse effects , Lichen Planus/chemically induced , Psoriasis/drug therapy , Child , Etanercept , Humans , Immunoglobulin G/administration & dosage , Immunosuppressive Agents/administration & dosage , Male , Receptors, Tumor Necrosis Factor/administration & dosage , Severity of Illness IndexABSTRACT
A 39-year-old man with human immunodeficiency virus infection and Kaposi sarcoma on HAART therapy and doxorubicin presented in 2007 with a hyperpigmented tongue. Physical examination also showed hyperpigmented patches on the mucosal aspects of the lips and longitudinal dark bands on multiple nails. A skin biopsy specimen showed pigmentary alteration. Such hyperpigmentation has been described in numerous case reports and case series and has been reported to resolve within weeks to months of cessation of doxorubicin.
Subject(s)
Antineoplastic Agents/adverse effects , Doxorubicin/adverse effects , Lip Diseases/chemically induced , Melanosis/chemically induced , Nails, Malformed/chemically induced , Sarcoma, Kaposi/drug therapy , Tongue Diseases/chemically induced , Acquired Immunodeficiency Syndrome/complications , Adult , Anti-HIV Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Antiretroviral Therapy, Highly Active , Carbamates/therapeutic use , Doxorubicin/therapeutic use , Drug Combinations , Furans , Humans , Lamivudine/therapeutic use , Male , Organophosphates/therapeutic use , Ritonavir/therapeutic use , Sarcoma, Kaposi/complications , Sulfonamides/therapeutic use , Zidovudine/therapeutic useABSTRACT
An 80-year-old man presented with a 50-year history of asymptomatic, subcutaneous masses on the arms, trunk, and legs. His father and maternal grandmother had had similar lesions. Histopathologic examination showed a benign angiolipoma; the same diagnosis has been made on several previous biopsy specimens. This patient's history and physical examination support the diagnosis of familial angiolipomatosis, which is a benign, autosomal-dominant condition that may be regarded as a subtype of familial multiple lipomatosis (FML) or as a distinct entity. Management of this condition may include liposuction or surgery to reduce the tumor burden.
Subject(s)
Angiomatosis/genetics , Lipomatosis, Multiple Symmetrical/genetics , Aged, 80 and over , Angiomatosis/pathology , Diagnosis, Differential , Humans , Lipomatosis, Multiple Symmetrical/pathology , Male , Severity of Illness Index , Skin/pathologySubject(s)
Laser Therapy/adverse effects , Humans , Laser Therapy/methods , Lasers , Rejuvenation , Skin Aging , Wound HealingABSTRACT
CONTEXT: The incidence of cutaneous melanoma has increased over the past several decades, making its early diagnosis a continuing public health priority. The ABCD (Asymmetry, Border irregularity, Color variegation, Diameter >6 mm) acronym for the appraisal of cutaneous pigmented lesions was devised in 1985 and has been widely adopted but requires reexamination in light of recent data regarding the existence of small-diameter (< or =6 mm) melanomas. EVIDENCE ACQUISITION: Cochrane Library and PubMed searches for the period 1980-2004 were conducted using search terms ABCD and melanoma and small-diameter melanoma. Bibliographies of retrieved articles were also used to identify additional relevant information. EVIDENCE SYNTHESIS: Available data do not support the utility of lowering the diameter criterion of ABCD from the current greater than 6 mm guideline. However, the data support expansion to ABCDE to emphasize the significance of evolving pigmented lesions in the natural history of melanoma. Physicians and patients with nevi should be attentive to changes (evolving) of size, shape, symptoms (itching, tenderness), surface (especially bleeding), and shades of color. CONCLUSIONS: The ABCD criteria for the gross inspection of pigmented skin lesions and early diagnosis of cutaneous melanoma should be expanded to ABCDE (to include "evolving"). No change to the existing diameter criterion is required at this time.
Subject(s)
Melanoma/diagnosis , Skin Neoplasms/diagnosis , Humans , Practice Guidelines as TopicABSTRACT
OBJECTIVE: To determine the utility of the current diameter criterion of larger than 6 mm of the ABCDE acronym for the early diagnosis of cutaneous melanoma. DESIGN: Cohort study. SETTING: Dermatology hospital-based clinics and community practice offices. Patients A total of 1323 patients undergoing skin biopsies of 1657 pigmented lesions suggestive of melanoma. MAIN OUTCOME MEASURE: The maximum lesion dimension (diameter) of each skin lesion was calculated before biopsy using a novel computerized skin imaging system. RESULTS: Of 1657 biopsied lesions, 853 (51.5%) were 6 mm or smaller in diameter. Invasive melanomas were diagnosed in 13 of 853 lesions (1.5%) that were 6 mm or smaller in diameter and in 41 of 804 lesions (5.1%) that were larger than 6 mm in diameter. In situ melanomas were diagnosed in 22 of 853 lesions (2.6%) that were 6 mm or smaller in diameter and in 62 of 804 lesions (7.7%) that were larger than 6 mm in diameter. Conclusion The diameter guideline of larger than 6 mm provides a useful parameter for physicians and should continue to be used in combination with the A, B, C, and E criteria previously established in the selection of atypical lesions for skin biopsy.